Vicarious Surgical Executives Voluntarily Cut Salaries Amidst Delisting
summarizeSummary
Vicarious Surgical's President and CTO voluntarily reduced their base salaries by 50% and 25% respectively, signaling significant cost-cutting efforts following the company's NYSE delisting.
check_boxKey Events
-
Executive Salary Reductions
President Adams Sachs's annual base salary was voluntarily reduced by 50% to approximately $270,810, and CTO Sammy Khalifa's annual base salary was reduced by 25% to approximately $318,600.
-
Voluntary Agreement and Waiver
Both executives voluntarily agreed to the salary reductions and explicitly waived any right to assert that these reductions constitute 'Good Reason' for severance claims under their employment agreements.
-
Preservation of Severance/Bonus Basis
Despite the immediate salary cuts, target bonus amounts and severance payments will continue to be calculated based on the executives' higher base salaries in effect prior to these amendments.
-
Context of Delisting
These cost-cutting measures follow the company's recent notification on March 4, 2026, of its immediate trading suspension and delisting from the NYSE, with trading now on the OTCID market.
auto_awesomeAnalysis
This filing details significant voluntary salary reductions for Vicarious Surgical's President and Chief Technology Officer. The President's base salary was cut by 50% and the CTO's by 25%. While these reductions are voluntary and preserve higher base salaries for future bonus and severance calculations, they signal aggressive cost-cutting measures in response to the company's severe financial distress, including its recent NYSE delisting and trading near 52-week lows. This move is a necessary step to conserve cash and extend the company's operational runway, but it underscores the challenging environment the company faces.
At the time of this filing, RBOT was trading at $0.27 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.27 to $13.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.